Transcription of Public Assessment Report Repeat-Use Mutual Recognition ...
{{id}} {{{paragraph}}}
Example: stock market
Public Assessment Report Repeat-Use Mutual Recognition ...
Public Assessment Report Repeat-Use Mutual Recognition Procedure VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03 UK Licence No: PL 21727/0016-0017 Grunenthal Limited MRPAR Versatis/Lidocaine 5% Medicated Plaster UK/H/1040-1041/001/E03 2 LAY SUMMARY VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (lidocaine) This is a summary of the Public Assessment Report (PAR) for Versatis/Lidocaine 5% Medicated Plaster (PL 21727/0016-0017). It explains how Versatis/Lidocaine 5% Medicated Plaster w as assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Versatis/Lidocaine 5% Medicated Plaster. For practical information about using Versatis/Lidocaine 5% Medicated Plaster, patients should read the package leaflet or contact their doctor or pharmacist.
The usual daily dose is to use between one and three plasters of the size of the painful areas of skin. Versatis/Lidocaine may be cut into smaller pieces to fit the affected area.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: